- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00006341
Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer
Efficacy of Implant-Supported Maxillofacial Prostheses
RATIONALE: The use of dentures and dental implants may help maintain chewing and speaking ability following surgery to remove tumors in the mouth.
PURPOSE: Phase II trial to study the effectiveness of dentures and dental implants in maintaining the ability to chew and speak in patients undergoing surgery for mouth cancer.
Aperçu de l'étude
Description détaillée
OBJECTIVES:
- Determine whether conventional or implant supported dental prostheses and current surgical reconstructive procedures restore oral function and quality of life to pre-cancer surgery levels in patients with early oral cancer.
OUTLINE: Patients complete a series of objective and subjective functional tests, questionnaires, and baseline examinations. Within 1-5 days, patients undergo the composite resection, including reconstructive surgery for the mandibulectomy group. Patients in the maxillectomy group receive an immediate maxillary surgical obturator. Approximately 6 weeks after ablative surgery, some patients receive radiotherapy for 5-7 weeks.
Patients receive 2-4 implants at 12-16 weeks after completion of radiotherapy or 8-16 weeks after ablative surgery. Patients then receive conventional dentures at 4-22 weeks after implant surgery. Implants are exposed during 27-48 weeks after placement and abutments connected for fabricating dental prostheses. Approximately 8 weeks are needed to fabricate the implant supported prosthesis.
Patients complete quality of life and other questionnaires prior to and at 8-21 weeks after surgery, 16 weeks after conventional denture insertion, and then 16 weeks after implant supported prosthesis insertion.
Patients are followed every 6 months for at least 3 years.
PROJECTED ACCRUAL: A total of 62 patients (22 requiring maxillectomy and 40 requiring mandibulectomy) will be accrued for this study within 42 months.
Type d'étude
Inscription (Réel)
Phase
- Phase 2
Contacts et emplacements
Lieux d'étude
-
-
California
-
Los Angeles, California, États-Unis, 90095-1781
- Jonsson Comprehensive Cancer Center, UCLA
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
DISEASE CHARACTERISTICS:
Diagnosis of early oral cancer lesions requiring one of the following:
- Partial or total unilateral maxillectomy OR
- Partial lateral mandibulectomy with or without partial glossectomy
- Edentulous or edentulous in the maxillary arch prior to or after ablative surgery (maxillectomy group)
- Partial mandibulectomy leaving the condyles intact bilaterally (mandibulectomy group)
- Must have sufficient bone in the selected implant sites to accommodate 2-4 implants of at least 10 mm in length
- No temporomandibular dysfunction and/or functionally restrictive opening
- No requirement for total glossectomy, reconstructive maxillary surgery, or maxillary sinus lift
- No requirement for radiotherapy after mandibular reconstructive surgery
PATIENT CHARACTERISTICS:
Age:
- 35 to 80
Performance status:
- Not specified
Life expectancy:
- Not specified
Hematopoietic:
- Not specified
Hepatic:
- Not specified
Renal:
- Not specified
Other:
- No oral discomfort that would preclude study
- No complications after ablative or reconstructive surgery that would preclude dental rehabilitation with implants
PRIOR CONCURRENT THERAPY:
Biologic therapy:
- Not specified
Chemotherapy:
- Not specified
Endocrine therapy:
- Not specified
Radiotherapy:
- See Disease Characteristics
- No prior or concurrent radiotherapy of greater than 5,500 cGY to potential implant site
Surgery:
- See Disease Characteristics
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: Implant
A total of 62 patients with early oral cancer will be recruited; in addition, 22 patients requiring a partial maxillectomy and 40 requiring a partial lateral mandibulectomy will be enrolled.
The mandibular defects will be reconstructed with fibula free flap surgery.
Following a healing period, implants will be placed and permitted to heal unloaded for six months.
Conventional dental prostheses will be fabricated and used by patients for at least 16 weeks during Phase I healing before the implants are exposed and loaded.
A few weeks after Phase II surgery, the patients will receive implant-supported dental prostheses.
|
A total of 62 patients with early oral cancer will be recruited; in addition, 22 patients requiring a partial maxillectomy and 40 requiring a partial lateral mandibulectomy will be enrolled.
The mandibular defects will be reconstructed with fibula free flap surgery.
Following a healing period, implants will be placed and permitted to heal unloaded for six months.
Conventional dental prostheses will be fabricated and used by patients for at least 16 weeks during Phase I healing before the implants are exposed and loaded.
A few weeks after Phase II surgery, the patients will receive implant-supported dental prostheses.
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chaise d'étude: Neal R. Garrett, PhD, Jonsson Comprehensive Cancer Center
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CDR0000066588
- UCLA-HSPC-940205413
- UCLA-DEN-1R01DE11255
- UCLA-HSPC-940205411
- NCI-V00-1606
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Cancer de la tête et du cou
-
Mathematica Policy Research, Inc.Boston Children's Hospital; Department of Health and Human ServicesPas encore de recrutementIntervention précoce, éducation (Head Start et Early Head Start Access and Participation)États-Unis
-
Novartis PharmaceuticalsRecrutementAdvanced EGFRmutant NonSmallSellLungCancer (NSCLC),KRAS G12-mutant NSCLC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,MélanomePays-Bas, Corée, République de, Espagne, Taïwan, Japon, Italie, Canada, États-Unis, Singapour
Essais cliniques sur Implant
-
University of Sao PauloComplétéCataracte | AstigmatismeBrésil
-
Mentor Worldwide, LLCRetiréAugmentation | Révision d'augmentation | Augmentation mammaire générale | Involution post-lactationnelle | AsymétrieÉtats-Unis
-
Cairo UniversityPas encore de recrutementÉdenté ; Processus alvéolaire, atrophie
-
ZimVieComplétéÉdentement partiel | Maladie des dentsÉtats-Unis
-
Nobel BiocareComplétéÉdentement partiel | Édentement complet
-
University Hospital, ToursComplété
-
Ideal Implant IncorporatedComplétéImplants mammairesÉtats-Unis
-
University of BarcelonaGeistlich Pharma AG; Adin ImplantsInconnueImplant dentaire | Régénération osseuse guidée | Implant étroit | Fracture de l'implantEspagne
-
University of BariComplété
-
University of OxfordComplétéRétinite pigmentaireRoyaume-Uni